LON:POLX Polarean Imaging (POLX) Share Price, News & Analysis → why 99.94% won’t make you money (From Prosper Trading Academy) (Ad) Free POLX Stock Alerts GBX 1.40 +0.08 (+5.66%) (As of 11:57 AM ET) Add Compare Share Share Today's Range 1▼ 1.4050-Day Range 1.18▼ 4.0252-Week Range 1▼ 30Volume52.04 million shsAverage Volume3.92 million shsMarket Capitalization£3.03 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Get Polarean Imaging alerts: Email Address Ad Behind the MarketsWill this AI Micro-Cap be Bigger than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout AI stock. But right now... There's only ONE AI stock you should be watching.Get the full story here >>> About Polarean Imaging Stock (LON:POLX)Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas polarizer devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; and measurement station, chest coil, and dose delivery inhalation bags. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.Read More POLX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart POLX Stock News HeadlinesJune 15 at 4:44 AM | americanbankingnews.comPolarean Imaging (LON:POLX) Stock Price Down 11.5%January 9, 2024 | finance.yahoo.comPolarean Imaging (LON:POLX) Will Have To Spend Its Cash WiselyJune 18, 2024 | Paradigm Press (Ad)Musk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840.December 21, 2023 | finance.yahoo.comPolarean Imaging "very excited" to announce brand new customer for XENOVIEW polariserOctober 23, 2023 | uk.investing.comPOLX Historical DataSeptember 27, 2023 | proactiveinvestors.comPolarean Imaging appoints new non-executive directorAugust 29, 2023 | finance.yahoo.comCMS grants reimbursement code for the Polarean XENOVIEW™ MRI TechnologyJuly 10, 2023 | finance.yahoo.comWe're Keeping An Eye On Polarean Imaging's (LON:POLX) Cash Burn RateJune 18, 2024 | Paradigm Press (Ad)Musk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840.June 22, 2023 | bizjournals.comDurham medtech names new CEO to steer commercial launchJune 21, 2023 | finanznachrichten.dePolarean Imaging plc: Appointment of Dr. Christopher von Jako as new CEOMay 29, 2023 | finance.yahoo.comRecent 10% pullback isn't enough to hurt long-term Polarean Imaging (LON:POLX) shareholders, they're still up 59% over 5 yearsMay 26, 2023 | proactiveinvestors.comPolarean Imaging focused on gaining commercial traction for XENOVIEWMay 19, 2023 | msn.comThis penny stock has halved in 2023 to 28p! Should I buy?May 12, 2023 | marketwatch.comFirst clinical scan using XENOVIEW conducted at Cincinnati Children's Hospital Medical CenterMay 11, 2023 | finance.yahoo.comFirst clinical scan using XENOVIEW conducted at Cincinnati Children’s Hospital Medical CenterApril 17, 2023 | proactiveinvestors.comPolarean Imaging hires consultant to support commercial planningMarch 14, 2023 | proactiveinvestors.comPolarean Imaging gains access to funds after new bridge bank is formed; share suspension liftedMarch 13, 2023 | finance.yahoo.comU.K. tech, life sciences firms outline exposure to failed SVBFebruary 13, 2023 | proactiveinvestors.comPolarean Imaging looking to gain commercial traction for its XENOVIEWDecember 28, 2022 | proactiveinvestors.comPolarean Imaging PLC surges as XENOVIEW gets FDA green lightDecember 28, 2022 | proactiveinvestors.comPolarean Imaging surges as XENOVIEW gets FDA green lightNovember 29, 2022 | finance.yahoo.comPolarean Imaging plc (LON:POLX) has caught the attention of institutional investors who hold a sizeable 44% stakeOctober 27, 2022 | finance.yahoo.comPolarean Imaging's (LON:POLX) investors will be pleased with their notable 96% return over the last three yearsSeptember 22, 2022 | proactiveinvestors.comPolarean Imaging says US FDA requests additional information from manufacturing partner of its xenon-129 gas blend drugSeptember 6, 2022 | finance.yahoo.comPolarean Imaging plc (POLX.L)August 31, 2022 | marketwatch.comPolarean Imaging 1H Pretax Loss Widened on Greater Expenses, FX LossesSee More Headlines Receive POLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Polarean Imaging and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolLON:POLX CUSIPN/A CIKN/A Webwww.polarean.com Phone919 206 7900FaxN/AEmployees28Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-14,340,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-75.33% Return on Assets-40.85% Debt Debt-to-Equity Ratio2.30 Current Ratio5.50 Quick Ratio9.80 Sales & Book Value Annual Sales£1.03 million Price / Sales2.78 Cash FlowGBX 0.27 per share Price / Cash Flow4.93 Book ValueGBX 6 per share Price / Book0.22Miscellaneous Outstanding Shares216,260,000Free FloatN/AMarket Cap£2.87 million OptionableNot Optionable Beta0.69 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Kenneth Paul West (Age 67)Chairman of the Board Comp: $44.55kDr. Bastiaan Driehuys Ph.D. (Age 54)Founder, Chief Scientific Officer & Director Comp: $28.65kMr. Charles Fremont Osborne Jr. (Age 58)CFO & Director Comp: $268.56kDr. Christopher Richard Von Jako Ph.D. (Age 54)CEO & Director Mr. Neil Wadehra (Age 44)Vice President of Operations Mr. Alex Dusek (Age 57)Chief Commercial Officer Mr. Stephen AustinCompany SecretaryMore ExecutivesKey CompetitorsAdvanced OncotherapyLON:AVORUA Life SciencesLON:RUAMyHealthCheckedLON:MHCSurgical Innovations GroupLON:SUNDeltex Medical GroupLON:DEMGView All Competitors POLX Stock Analysis - Frequently Asked Questions How have POLX shares performed in 2024? Polarean Imaging's stock was trading at GBX 6.25 at the beginning of the year. Since then, POLX shares have decreased by 77.6% and is now trading at GBX 1.40. View the best growth stocks for 2024 here. What other stocks do shareholders of Polarean Imaging own? Based on aggregate information from My MarketBeat watchlists, some companies that other Polarean Imaging investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP). How do I buy shares of Polarean Imaging? Shares of POLX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:POLX) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Polarean Imaging plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Polarean Imaging With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
